Sanofi launches insulin "monthly payment of $35" plan in the United States.

Sanofi US announced on September 26th that its "Insulin Savings Program" will be significantly expanded to cover a wider range. Any US patient with a valid prescription can now purchase any Sanofi insulin for a 30-day supply for $35. The program was originally established for the uninsured population, but will now be open to all US residents, regardless of their insurance status - including those with commercial insurance or Medicare. The expanded "Insulin Savings Program" now ensures that every American patient will not pay more than $35 for their Sanofi insulin each month.